Prognostic Utility of Pretreatment Neutrophil-Lymphocyte Ratio in Advanced Larynx Cancer.
Nikhil V KothaRohith S VooraAlexander S QianAbhishek KumarEdmund M QiaoTyler F StewartBrent S RoseRyan K OroscoPublished in: Biomarker insights (2021)
In locoregionally advanced larynx cancer treated with curative intent, we identified elevated NLR to be associated with inferior OS and CSS. Further prospective studies are needed to investigate pretreatment NLR and our identified 4.17 cutoff as a potential larynx cancer-specific marker for this high risk population.